| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $128.4M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | HROW Harrow, Inc. | - | Buy | 106,416 | $5.26 | $559,482.03 | +1.2% | |
| Oct 16, 2020 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 400,000 | $7.00 | $2,800,000.00 | +11.0% | |
| Sep 30, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $16.00 | $800,000.00 | +2.1% | |
| Sep 24, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 300,000 | $16.87 | $5,061,000.00 | +13.6% | |
| Jul 12, 2020 | HROW Harrow, Inc. | - | Buy | 112,700 | $4.97 | $560,132.67 | +1.3% | |
| Jul 9, 2020 | HROW Harrow, Inc. | - | Buy | 136,300 | $5.02 | $683,703.95 | +1.7% | |
| Jun 19, 2020 | HROW Harrow, Inc. | 10% Owner | Buy | 35,000 | $5.58 | $195,401.50 | +1.4% | |
| Jun 4, 2020 | HROW Harrow, Inc. | 10% Owner | Buy | 50,000 | $5.73 | $286,508.30 | +0.7% | |
| May 22, 2020 | HROW Harrow, Inc. | 10% Owner | Buy | 25,900 | $4.85 | $125,665.89 | +0.3% | |
| Jan 2, 2020 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 15,000 | $3.90 | $58,507.50 | +0.3% |